Brief: Theratechnologies Gets March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation Sbla
10/12/2024 20:17
Dec 10 (Reuters) - Theratechnologies Inc TH.TO :
* RECEIVES MARCH 2025 PDUFA GOAL DATE FOR UPDATED
TESAMORELIN F8
FORMULATION SBLA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process